ANXO PHARMACEUTICAL CO LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of 6677 for the last semiannual is 494.76 M TWD, and it's 11.14% higher compared to the previous semiannual. The net income of H2 23 is 15.35 M TWD.